SEC Insider Transactions from AULIN SHERRY.

Last updated: 2026-03-14 10:10 UTC | Total transactions: 9

AULIN SHERRY has filed 9 insider transactions across 1 company since March 2024.

Most recent transaction: a option exercise of 9334 shares of Xenon Pharmaceuticals Inc. ($XENE) on December 18, 2024.

Activity breakdown: 0 open-market purchases and 2 sales.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Dec. 18, 2024 Xenon Pharmaceuticals Inc. $XENE AULIN SHERRY Chief Financial Officer M Common Shares 9334 $9.44 9,334.0000 77,926,205 9999.99% 0.01%
Dec. 18, 2024 Xenon Pharmaceuticals Inc. $XENE AULIN SHERRY Chief Financial Officer F Common Shares 2135 $41.28 7,199.0000 77,926,205 22.87% 0.00%
Dec. 18, 2024 Xenon Pharmaceuticals Inc. $XENE AULIN SHERRY Chief Financial Officer S Common Shares 7199 $41.23 0.0000 77,926,205 100.00% 0.01%
Dec. 18, 2024 Xenon Pharmaceuticals Inc. $XENE AULIN SHERRY Chief Financial Officer M Common Shares 16000 $11.58 16,000.0000 77,926,205 9999.99% 0.02%
Dec. 18, 2024 Xenon Pharmaceuticals Inc. $XENE AULIN SHERRY Chief Financial Officer F Common Shares 4490 $41.28 11,510.0000 77,926,205 28.06% 0.01%
Dec. 18, 2024 Xenon Pharmaceuticals Inc. $XENE AULIN SHERRY Chief Financial Officer S Common Shares 11510 $41.19 0.0000 77,926,205 100.00% 0.01%
Dec. 18, 2024 Xenon Pharmaceuticals Inc. $XENE AULIN SHERRY Chief Financial Officer M Stock Option (Right to Buy) 9334 $0.00 0.0000 77,926,205 100.00% 0.01%
Dec. 18, 2024 Xenon Pharmaceuticals Inc. $XENE AULIN SHERRY Chief Financial Officer M Stock Option (Right to Buy) 16000 $0.00 6,000.0000 77,926,205 72.73% 0.02%
March 11, 2024 Xenon Pharmaceuticals Inc. $XENE AULIN SHERRY Chief Financial Officer A Stock Option (Right to Buy) 100000 $0.00 100,000.0000 66,889,005 9999.99% 0.15%